These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
288 related articles for article (PubMed ID: 32496505)
41. Identification of the key pathways and genes involved in HER2-positive breast cancer with brain metastasis. Lu X; Gao C; Liu C; Zhuang J; Su P; Li H; Wang X; Sun C Pathol Res Pract; 2019 Aug; 215(8):152475. PubMed ID: 31178227 [TBL] [Abstract][Full Text] [Related]
42. Gene network inference and biochemical assessment delineates GPCR pathways and CREB targets in small intestinal neuroendocrine neoplasia. Drozdov I; Svejda B; Gustafsson BI; Mane S; Pfragner R; Kidd M; Modlin IM PLoS One; 2011; 6(8):e22457. PubMed ID: 21853033 [TBL] [Abstract][Full Text] [Related]
43. Identification of hub genes in chronically hypoxic myocardium using bioinformatics analysis. Wu F; Gao F; He S; Xiao Y Mol Med Rep; 2019 May; 19(5):3871-3881. PubMed ID: 30864710 [TBL] [Abstract][Full Text] [Related]
44. Identification and validation of key genes with prognostic value in non-small-cell lung cancer via integrated bioinformatics analysis. Wang L; Qu J; Liang Y; Zhao D; Rehman FU; Qin K; Zhang X Thorac Cancer; 2020 Apr; 11(4):851-866. PubMed ID: 32059076 [TBL] [Abstract][Full Text] [Related]
45. Identification of hub genes to regulate breast cancer metastasis to brain by bioinformatics analyses. Tang D; Zhao X; Zhang L; Wang Z; Wang C J Cell Biochem; 2019 Jun; 120(6):9522-9531. PubMed ID: 30506958 [TBL] [Abstract][Full Text] [Related]
46. Microarray based analysis of gene expression patterns in pancreatic neuroendocrine tumors. Wang DD; Liu ZW; Han MM; Zhu ZM; Tu YL; Dou CQ; Jin X; Cai SW; Du N Eur Rev Med Pharmacol Sci; 2015 Sep; 19(18):3367-74. PubMed ID: 26439030 [TBL] [Abstract][Full Text] [Related]
47. Identification of differentially expressed genes and enriched pathways in lung cancer using bioinformatics analysis. Long T; Liu Z; Zhou X; Yu S; Tian H; Bao Y Mol Med Rep; 2019 Mar; 19(3):2029-2040. PubMed ID: 30664219 [TBL] [Abstract][Full Text] [Related]
48. Bioinformatics analysis of differentially expressed gene profiles associated with systemic lupus erythematosus. Wu C; Zhao Y; Lin Y; Yang X; Yan M; Min Y; Pan Z; Xia S; Shao Q Mol Med Rep; 2018 Mar; 17(3):3591-3598. PubMed ID: 29257335 [TBL] [Abstract][Full Text] [Related]
49. Identification and Integrated Analysis of Key Biomarkers for Diagnosis and Prognosis of Non-Small Cell Lung Cancer. Liu X; Liu X; Li J; Ren F Med Sci Monit; 2019 Dec; 25():9280-9289. PubMed ID: 31805030 [TBL] [Abstract][Full Text] [Related]
50. Molecular mechanisms underlying gliomas and glioblastoma pathogenesis revealed by bioinformatics analysis of microarray data. Vastrad B; Vastrad C; Godavarthi A; Chandrashekar R Med Oncol; 2017 Sep; 34(11):182. PubMed ID: 28952134 [TBL] [Abstract][Full Text] [Related]
51. Extracellular matrix-related genes play an important role in the progression of NMIBC to MIBC: a bioinformatics analysis study. Zhang H; Shan G; Song J; Tian Y; An LY; Ban Y; Luo GH Biosci Rep; 2020 May; 40(5):. PubMed ID: 32391563 [TBL] [Abstract][Full Text] [Related]
52. A comprehensive analysis of candidate genes and pathways in pancreatic cancer. Liu J; Li J; Li H; Li A; Liu B; Han L Tumour Biol; 2015 Mar; 36(3):1849-57. PubMed ID: 25409614 [TBL] [Abstract][Full Text] [Related]
53. Prognostic values and prospective pathway signaling of MicroRNA-182 in ovarian cancer: a study based on gene expression omnibus (GEO) and bioinformatics analysis. Li Y; Li L J Ovarian Res; 2019 Nov; 12(1):106. PubMed ID: 31703725 [TBL] [Abstract][Full Text] [Related]
54. Transcriptomic analysis and identification of prognostic biomarkers in cholangiocarcinoma. Li H; Long J; Xie F; Kang K; Shi Y; Xu W; Wu X; Lin J; Xu H; Du S; Xu Y; Zhao H; Zheng Y; Gu J Oncol Rep; 2019 Nov; 42(5):1833-1842. PubMed ID: 31545466 [TBL] [Abstract][Full Text] [Related]
55. Identification of key genes and pathways of thyroid cancer by integrated bioinformatics analysis. Liu L; He C; Zhou Q; Wang G; Lv Z; Liu J J Cell Physiol; 2019 Dec; 234(12):23647-23657. PubMed ID: 31169306 [TBL] [Abstract][Full Text] [Related]
56. Topological network analysis of differentially expressed genes in cancer cells with acquired gefitinib resistance. Lee YS; Hwang SG; Kim JK; Park TH; Kim YR; Myeong HS; Kwon K; Jang CS; Noh YH; Kim SY Cancer Genomics Proteomics; 2015; 12(3):153-66. PubMed ID: 25977174 [TBL] [Abstract][Full Text] [Related]
57. Chemo-resistant Gastric Cancer Associated Gene Expression Signature: Bioinformatics Analysis Based on Gene Expression Omnibus. Liu JB; Jian T; Yue C; Chen D; Chen W; Bao TT; Liu HX; Cao Y; Li WB; Yang Z; Hoffman RM; Yu C Anticancer Res; 2019 Apr; 39(4):1689-1698. PubMed ID: 30952707 [TBL] [Abstract][Full Text] [Related]
58. Biomarker identification and trans-regulatory network analyses in esophageal adenocarcinoma and Barrett's esophagus. Lv J; Guo L; Wang JH; Yan YZ; Zhang J; Wang YY; Yu Y; Huang YF; Zhao HP World J Gastroenterol; 2019 Jan; 25(2):233-244. PubMed ID: 30670912 [TBL] [Abstract][Full Text] [Related]
59. Identification of Key Genes and Signaling Pathways Associated with the Progression of Gastric Cancer. Yu C; Chen J; Ma J; Zang L; Dong F; Sun J; Zheng M Pathol Oncol Res; 2020 Jul; 26(3):1903-1919. PubMed ID: 31848941 [TBL] [Abstract][Full Text] [Related]
60. Identification of key pathogenic genes of sepsis based on the Gene Expression Omnibus database. Lu X; Xue L; Sun W; Ye J; Zhu Z; Mei H Mol Med Rep; 2018 Feb; 17(2):3042-3054. PubMed ID: 29257295 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]